Data / Drug companies / Dextrum Laboratories, Inc
Dextrum Laboratories, Inc: 21 products in the FDA NDC directory, labeler code 65852
Dextrum Laboratories, Inc (labeler code 65852) lists 21 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 21 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on April 11, 2024.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 65852
- Products in commercial distribution
- 21
- Packages
- 21
- Finished drugs by generic name
- 9
- Prescription products
- 0
- Over the counter products
- 21
- Flagged as original packager
- 21 of 21 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 1, 2004
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 21 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 21 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Dextromethorphan hydrobromide, guaifenesin | 3 | 49 |
| Dextromethorphan hbr | 2 | 22 |
| Guaifenesin | 2 | 123 |
| Dextromethorphan hbr, guaifenesin | 2 | 67 |
| Benzocaine, menthol, zinc chloride | 1 | 3 |
| Benzocaine | 1 | 110 |
| Giltuss d | 1 | 2 |
| Brompheniramine maleate, dextromethorphan hbr | 1 | 3 |
| Lidocaine hydrochloride | 1 | 134 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 11 | 52.4% |
| Liquid | 6 | 28.6% |
| Syrup | 2 | 9.5% |
| Spray | 2 | 9.5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Giltuss D | 65852-010 | Syrup | Over the counter monograph drugs | April 11, 2024 |
| Rompe Pecho CF | 65852-013 | Liquid | Over the counter monograph drugs | October 1, 2023 |
| IceQuake Lidocaine Analgesic | 65852-026 | Liquid | Over the counter monograph drugs | August 1, 2022 |
| Childrens Giltuss EX Expectorant | 65852-016 | Solution | Over the counter monograph drugs | June 22, 2020 |
| Giltuss EX Expectorant | 65852-008 | Solution | Over the counter monograph drugs | June 22, 2020 |
| Childrens Giltuss Honey DM Cough | 65852-007 | Liquid | Over the counter monograph drugs | June 22, 2020 |
| Giltuss Honey Cough and Chest Congestion | 65852-005 | Liquid | Over the counter monograph drugs | June 22, 2020 |
| Giltuss Honey DM Cough | 65852-004 | Solution | Over the counter monograph drugs | June 22, 2020 |
| Childrens Giltuss Honey Cough and Chest Congestion | 65852-003 | Solution | Over the counter monograph drugs | June 22, 2020 |
| Giltuss HBP Cough and Chest Congestion | 65852-006 | Solution | Over the counter monograph drugs | November 13, 2018 |
| Giltuss Childrens Allergy Plus | 65852-018 | Solution | Over the counter monograph drugs | November 7, 2018 |
| Giltuss Childrens Cough and Cold | 65852-011 | Solution | Over the counter monograph drugs | November 7, 2018 |
| Giltuss Diabetic | 65852-009 | Solution | Over the counter monograph drugs | October 17, 2018 |
| Giltuss Childrens Cough and Chest Congestion | 65852-019 | Solution | Over the counter monograph drugs | October 2, 2018 |
| Giltuss Allergy Plus | 65852-017 | Solution | Over the counter monograph drugs | October 2, 2018 |
| Giltuss Cough and Cold | 65852-012 | Solution | Over the counter monograph drugs | October 2, 2018 |
| Giltuss Bucalsep | 65852-015 | Spray | Over the counter monograph drugs | July 26, 2018 |
| Dometuss | 65852-002 | Liquid | Over the counter monograph drugs | January 21, 2016 |
| Supress a | 65852-020 | Syrup | Over the counter monograph drugs | August 1, 2012 |
| Rycontuss | 65852-021 | Liquid | Over the counter monograph drugs | May 31, 2011 |
| Finafta MultiOral | 65852-001 | Spray | Over the counter monograph drugs | September 1, 2004 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.